GENETIC DEFECT OF COBALAMIN ABSORPTION IN DOGS
狗钴胺素吸收的遗传缺陷
基本信息
- 批准号:7153990
- 负责人:
- 金额:$ 0.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
It is now possible to isolate genes involved in genetic diseases and understand disease mechanisms in terms of the underlying molecular derangements, and there are encouraging new prospects for therapy for genetic diseases, including gene therapy. The full scope of understanding and treating genetic diseases in human patients cannot be realized without authentic (gene-homologous) animal models for studies not possible for ethical and practical reasons in human patients. Mouse gene knockout technology has provided a valuable source, but additional models are needed for studies requiring long-lived animals of larger size to be able to monitor clinical signs and with phenotypes more closely resembling the human diseases. A large reservoir of such models is present in existing animal populations and can be studied with the cooperation of breeders, veterinarians, and others interested in genetic disease control. The investigators have shown that this resource can be utilized by providing an accessible Center to ascertain, verify, and preserve these models. The objective of this project is to continue to serve as a NRC to identify, characterize, and make available for research, new animal models of human genetic disease. The models sought among laboratory, domesticated, and wild species, including nonhuman primates (NHPs), will involve defects in homologous gene loci having essentially the same molecular and clinical phenotypes as in human patients. Models offering new opportunities to investigate disease pathogenesis and approaches to therapy will be emphasized. The Center will provide the clinical, pathological, and molecular genetic studies required to establish homology with the human disorder. Verified models will be made available in the form of DNA, cells, frozen semen, breeding stock, and, in selected models, normal and mutant cDNAs.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN C FYFE其他文献
JOHN C FYFE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN C FYFE', 18)}}的其他基金
CONGENITAL HYPOTHYROIDISM IN GIANT SCHNAUZERS
巨型雪纳瑞的先天性甲状腺功能减退症
- 批准号:
7391959 - 财政年份:2006
- 资助金额:
$ 0.13万 - 项目类别:
CONGENITAL HYPOTHYROIDISM IN GIANT SCHNAUZERS
巨型雪纳瑞的先天性甲状腺功能减退症
- 批准号:
7153996 - 财政年份:2005
- 资助金额:
$ 0.13万 - 项目类别:
CONGENITAL HYPOTHYROIDISM IN GIANT SCHNAUZERS
巨型雪纳瑞的先天性甲状腺功能减退症
- 批准号:
7011854 - 财政年份:2004
- 资助金额:
$ 0.13万 - 项目类别:
Molecular Mechanism of Polarized Cubilin Expression
极化Cubilin表达的分子机制
- 批准号:
6732074 - 财政年份:2003
- 资助金额:
$ 0.13万 - 项目类别:
Molecular Mechanism of Polarized Cubilin Expression
极化Cubilin表达的分子机制
- 批准号:
6598635 - 财政年份:2003
- 资助金额:
$ 0.13万 - 项目类别:
MOLECULAR PATHOGENESIS OF FELINE SPINAL MUSCULAR ATROPHY
猫脊髓性肌萎缩症的分子发病机制
- 批准号:
6233658 - 财政年份:2001
- 资助金额:
$ 0.13万 - 项目类别:
MOLECULAR PATHOGENESIS OF FELINE SPINAL MUSCULAR ATROPHY
猫脊髓性肌萎缩症的分子发病机制
- 批准号:
6530558 - 财政年份:2001
- 资助金额:
$ 0.13万 - 项目类别:
MOLECULAR BASIS OF CONGENITAL THYROTROPIN DEFICIENCY
先天性促甲状腺激素缺乏症的分子基础
- 批准号:
6189892 - 财政年份:2000
- 资助金额:
$ 0.13万 - 项目类别:














{{item.name}}会员




